25.02.2016 KWS SAAT SE  DE0007074007

DGAP-News: KWS Group confirms net sales and EBIT targets

DGAP-News: KWS SAAT SE / Key word(s): Half Year Results KWS Group confirms net sales and EBIT targets 25.02.2016 / 07:30 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Einbeck, February 25, 2016 No. 15 | ww KWS Group confirms net sales and EBIT targets Revenue increased in the first half of the year - First-half income (EBIT) impacted by planned increase in spending on research and distribution - Expected EBIT margin of at least 10% at the end of the fiscal year confirmed KWS SAAT SE (ISIN: DE0007074007), one of the world's leading seed breeding companies, reports a rise in net sales for the KWS Group after the first six months of fiscal 2015/2016. Revenue increased sharply year on year by 13.1% to EUR219.5 million. Income (EBIT) is typically negative in the first half of the year and was impacted in particular by the planned increase in spending on research and development and on distribution. It was EUR-106.3 (-96.8) million. An EBIT margin for the KWS Group of at least 10% is still expected at the end of the fiscal year. "We are very pleased to be able to confirm our expectations for net sales and earnings at this point, because it wasn't necessarily a given in view of the currently challenging market climate in the agricultural sector," said Eva Kienle, Chief Financial Officer of KWS SAAT SE. "We're also managing that without jeopardizing our future growth, since expenditure on research & development and on distribution is being increased as planned." After the first half of the year, spending on research & development was EUR87.3 (78.7) million and selling expenses were EUR83.5 (74.9) million. Administrative expenses were EUR37.6 million, i.e. at about the same level of the previous year (EUR37.0 million), despite a sharp expansion in the volume of business. Operating income, which is usually negative at this time of the year, was EUR-106.3 (-96.8) million. Apart from spending on growth, the net effect from negative currency influences and higher cost of sales due to extreme weather in seed production were responsible for the year-on-year decline. Total capital expenditure in the first six months was EUR54.2 (78.7) million. It was sharply higher in the previous year due to the acquisition of the remaining shares in the French cereal breeder SOCIETÉ DE MARTINVAL S.A. (MOMONT). Segment reporting: All product segments grow net sales year on year Net sales in the Corn Segment were EUR115.7 (99.6) million, a year-on-year increase of 16.2%. Early sales of corn seed in North America and positive business performance in Argentina contributed to that. In Brazil, organic growth was offset by the significant devaluation in the real. In Europe, the performance of winter rapeseed business was particularly gratifying, with a sharp increase in revenue. The segment's income was mainly affected by higher expenditure on research & development and on distribution, as well as by negative exchange rate effects. In addition, extreme weather in South America and Europe resulted in bottlenecks in seed production in some regions. That increased the costs of sales. The segment's income at the end of the period under review was EUR-87.3 (-63.2) million. Net sales at the Sugarbeet Segment increased markedly in the first six months. Revenue rose to EUR46.9 (28.9) million, mainly due to higher early orders. The markets of the UK, the Netherlands and Turkey contributed to that in particular. Due to higher net sales and lower adverse exchange rate factors in Eastern Europe, the segment's income increased to EUR-28.6 (-42.2) million or by 32.2%. In view of low producer prices, net sales in the Cereal Segment were, as expected, restrained in the first half of 2015/2016. Although net sales rose slightly to EUR86.0 (83.7) million, this was mainly due to the previous year's acquisition in the French cereal market. Hybrid rye and wheat sales declined. However, winter barley business performed positively. The segment's income fell clearly to EUR19.0 (23.7) million, primarily due to the decline in the hybrid rye business. The Corporate Segment carries cross-segment function costs and research expenditures, and its only revenue comes from our farms. The segment's income developed as planned and was EUR-33.0 (-32.6) million in the first half of 2015/2016. Forecast: EBIT margin of at least 10% confirmed for 2015/2016 Although the general conditions in the market are challenging, KWS expects to grow net sales by 5% to 10% in the current fiscal year 2015/2016. The basis for this continued positive performance is the large number of marketing approvals for new high-performance varieties, which increased by almost 30% to 429 in the last fiscal year. We expect to gain market share in particular in the regions Southeastern and Eastern Europe, but also once again in South America. A crucial factor here will be how the currently strained market situation develops. Expenditure on future growth will be expanded moderately as planned. The research & development intensity is expected to be 17% to 18% of net sales at the end of the fiscal year. We confirm our earnings expectations from the last quarter and anticipate an EBIT margin of at least 10% for the KWS Group at the end of the fiscal year. Capital expenditure will again exceed EUR100 million, in particular due to expansion of our research and production structures and acquisition of access to new trait-technology. About KWS* KWS is one of the world's leading plant breeding companies. In fiscal 2014/15, 4,700 employees in 70 countries generated net sales of EUR 986 million and earnings before interest and taxes (EBIT) of EUR 113 million. A company with a tradition of family ownership, KWS has operated independently for some 160 years. It focuses on plant breeding and the production and sale of seed for corn, sugarbeet, cereals, potatoes, rapeseed and sunflowers. KWS uses leading-edge plant breeding methods to continuously improve yield and resistance to diseases, pests and abiotic stress. To that end, the company invested EUR 174 million last fiscal year in research and development, 17.7 percent of its net sales. For more information: www.kws.com. Follow us on Twitter(R) at https://twitter.com/KWS_Group. *All figures exclude KWS' 50/50 joint ventures AGRELIANT GENETICS LLC., AGRELIANT GENECTICS INC., GENECTIVE S.A. Contact: Wolf-Gebhard von der Wense Head of Investor Relations Phone +49 (0) 5561 311 968 Mobile +49 (0) 151 18 85 56 73 wolf-gebhard.vonderwense@kws.com KWS SAAT SE www.kws.com --------------------------------------------------------------------------- 25.02.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: KWS SAAT SE Grimsehlstraße 31 37555 Einbeck Germany Phone: +49 (0)5561 311-0 Fax: +49 (0)5561 311-322 E-mail: info@kws.com Internet: www.kws.de ISIN: DE0007074007 WKN: 707400 Indices: S-DAX Listed: Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News Service --------------------------------------------------------------------------- 439889 25.02.2016

Die wichtigsten Finanzdaten auf einen Blick
  2013 2014 2015 2016 2017 2018 2019e 2020e
Umsatzerlöse1 1.178,01 986,02 1.036,77 1.075,24 1.068,01 1.113,34 1.228,00 0,00
EBITDA1,2 184,20 159,33 160,95 180,94 182,42 198,72 200,00 0,00
EBITDA-Marge3 15,64 16,16 15,52 16,83 17,08 17,85 16,29 0,00
EBIT1,4 138,43 113,42 112,76 131,59 132,56 149,99 151,00 0,00
EBIT-Marge5 11,75 11,50 10,88 12,24 12,41 13,47 12,30 0,00
Jahresüberschuss1 80,29 84,05 85,28 97,71 99,66 104,02 107,00 0,00
Netto-Marge6 6,82 8,52 8,23 9,09 9,33 9,34 8,71 0,00
Cashflow1,7 61,02 48,12 125,86 122,35 98,06 72,85 76,00 0,00
Ergebnis je Aktie8 2,34 2,51 2.58 2,96 3,02 3,15 3,25 3,34
Dividende8 0,60 0,60 0,60 0,64 0,64 0,67 0,67 0,70
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2018 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ernst & Young

KWS Saat
WKN Kurs in € Einschätzung Börsenwert in Mio. €
707400 55,600 Kaufen 1.834,80
KGV 2021e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
16,02 17,91 0,938 20,07
1,95 25,19 1,65 9,878
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
0,67 0,70 1,21 17.12.2019
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
26.11.2019 25.02.2020 19.05.2020 23.10.2019
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-3,42% -7,90% -3,64% 0,72%
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu KWS SAAT SE  ISIN: DE0007074007 können Sie bei DGAP abrufen

Agrar , 707400 , KWS , XETR:KWS